BDSX

Biodesix Inc

SERVICES-MEDICAL LABORATORIES
LIFE SCIENCES

Prices are adjusted according to historical splits.

Biodesix Inc Stock Price

Vitals

Today's Low:
$1.0100
Today's High:
$1.1000
Open Price:
$1.1000
52W Low:
$0.955
52W High:
$8.34
Prev. Close:
$1.0400
Volume:
26779

Company Statistics

Market Cap.:
$0.041 billion
Book Value:
0.192
Revenue TTM:
$0.031 billion
Operating Margin TTM:
-162.5%
Gross Profit TTM:
$0.024 billion
Gross Profit TTM:
$0.024 billion
Profit Margin:
-179.8%
Return on Assets TTM:
-35.8%
Return on Equity TTM:
-336.1%

Company Profile

Biodesix Inc had its IPO on 2020-10-28 under the ticker symbol BDSX.

The company operates in the LIFE SCIENCES sector and SERVICES-MEDICAL LABORATORIES industry. Biodesix Inc has a staff strength of 0 employees.

Stock update

Shares of Biodesix Inc opened at $1.1 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $1.01 - $1.1, and closed at $1.02.

This is a -1.92% slip from the previous day's closing price.

A total volume of 26,779 shares were traded at the close of the day’s session.

In the last one week, shares of Biodesix Inc have increased by +2%.

Biodesix Inc's Key Ratios

Biodesix Inc has a market cap of $0.041 billion, indicating a price to book ratio of 5.26 and a price to sales ratio of 1.305.

In the last 12-months Biodesix Inc’s revenue was $0.031 billion with a gross profit of $0.024 billion and an EBITDA of $-0.047 billion. The EBITDA ratio measures Biodesix Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Biodesix Inc’s operating margin was -162.5% while its return on assets stood at -35.8% with a return of equity of -336.1%.

In Q2, Biodesix Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 7.9%.

Biodesix Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-1.818 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Biodesix Inc’s profitability.

Biodesix Inc stock is trading at a EV to sales ratio of 1.324 and a EV to EBITDA ratio of -0.89. Its price to sales ratio in the trailing 12-months stood at 1.305.

Biodesix Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Biodesix Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Biodesix Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Biodesix Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Biodesix Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Biodesix Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$1.02
52-Week High
$8.34
52-Week Low
$0.955
Analyst Target Price
$5

Biodesix Inc stock is currently trading at $1.02 per share. It touched a 52-week high of $8.34 and a 52-week low of $8.34. Analysts tracking the stock have a 12-month average target price of $5.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Biodesix Inc

The stock symbol (also called stock or share ticker) of Biodesix Inc is BDSX

The IPO of Biodesix Inc took place on 2020-10-28

Similar Industry Stocks (SERVICES-MEDICAL LABORATORIES)

Last Price
Chg
Chg%
Caredx Inc (CDNA)
$19.19
-0.86
-4.29%
$19.28
-0.48
-2.43%
Renalytix AI (RNLX)
$1.69
-0.08
-4.52%
Centogene B V (CNTG)
$0.88
-0.03
-3.74%
$2.2
0.03
+1.38%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company is headquartered in Boulder, Colorado.

Address

2970 WILDERNESS PLACE, SUITE 100, BOULDER, CO, US